Multivariate analysis: factors affecting molecular remission after transplantation
Group . | Relative ratio (95% CI) . | P . |
|---|---|---|
| 3 mo | ||
| Type of transplantation | 0.075 (0.02-0.028) | < .001 |
| LC30, × 109/L | 9.5 (2.9-30.2) | < .001 |
| 6 mo | ||
| Type of transplantation | 0.41 (0.005-0.34) | .003 |
| LC30, × 109/L | 37.3 (6.4-217.8) | < .001 |
| 12 mo | ||
| Type of transplantation | 0.09 (0.01-0.81) | .03 |
| LC30, × 109/L | 48.4 (4.5-518.6) | .001 |
Group . | Relative ratio (95% CI) . | P . |
|---|---|---|
| 3 mo | ||
| Type of transplantation | 0.075 (0.02-0.028) | < .001 |
| LC30, × 109/L | 9.5 (2.9-30.2) | < .001 |
| 6 mo | ||
| Type of transplantation | 0.41 (0.005-0.34) | .003 |
| LC30, × 109/L | 37.3 (6.4-217.8) | < .001 |
| 12 mo | ||
| Type of transplantation | 0.09 (0.01-0.81) | .03 |
| LC30, × 109/L | 48.4 (4.5-518.6) | .001 |
Comparisons were between PBSCTs and BMTs and LC30 above and below 0.30 × 109/L. Favorable factors were defined as PBSCT and LC30 above 0.30 × 109/L; unfavorable factors, as BMT and LC30 below 0.30 × 109/L.